Cargando…

A rare case of long‐term survival from metachronous bilateral adrenal metastasis of lung adenocarcinoma after combined surgical removal and immunochemotherapy

INTRODUCTION: The prognosis of adrenal metastasis from non‐small cell lung cancer is very poor. A recent report described the efficacy of the surgical removal of adrenal metastasis when solitary. However, metachronous bilateral adrenal metastasis is extremely rare, and a treatment strategy has not b...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomiyama, Nami, Naiki, Taku, Naiki‐Ito, Aya, Kawai, Tatsuya, Etani, Toshiki, Gonda, Masakazu, Aoki, Maria, Morikawa, Toshiharu, Sugiyama, Yosuke, Yasui, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626332/
https://www.ncbi.nlm.nih.gov/pubmed/36341191
http://dx.doi.org/10.1002/iju5.12519
_version_ 1784822706865176576
author Tomiyama, Nami
Naiki, Taku
Naiki‐Ito, Aya
Kawai, Tatsuya
Etani, Toshiki
Gonda, Masakazu
Aoki, Maria
Morikawa, Toshiharu
Sugiyama, Yosuke
Yasui, Takahiro
author_facet Tomiyama, Nami
Naiki, Taku
Naiki‐Ito, Aya
Kawai, Tatsuya
Etani, Toshiki
Gonda, Masakazu
Aoki, Maria
Morikawa, Toshiharu
Sugiyama, Yosuke
Yasui, Takahiro
author_sort Tomiyama, Nami
collection PubMed
description INTRODUCTION: The prognosis of adrenal metastasis from non‐small cell lung cancer is very poor. A recent report described the efficacy of the surgical removal of adrenal metastasis when solitary. However, metachronous bilateral adrenal metastasis is extremely rare, and a treatment strategy has not been established. CASE PRESENTATION: Herein, we describe a 52‐year‐old Asian male who presented with a right adrenal metastasis of non‐small cell lung cancer 8 months after immunochemotherapy and surgical resection of the lung. He underwent combined systemic treatment and a laparoscopic right adrenalectomy; however, after 9 months, a metachronous left adrenal metastasis emerged. A subsequent laparoscopic left adrenalectomy and systemic treatment led to long‐term progression‐free survival. CONCLUSION: The appropriate surgical indication and combined systemic treatment of a metachronous bilateral adrenal metastasis in non‐small cell lung cancer may extend the prognosis.
format Online
Article
Text
id pubmed-9626332
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-96263322022-11-03 A rare case of long‐term survival from metachronous bilateral adrenal metastasis of lung adenocarcinoma after combined surgical removal and immunochemotherapy Tomiyama, Nami Naiki, Taku Naiki‐Ito, Aya Kawai, Tatsuya Etani, Toshiki Gonda, Masakazu Aoki, Maria Morikawa, Toshiharu Sugiyama, Yosuke Yasui, Takahiro IJU Case Rep Case Reports INTRODUCTION: The prognosis of adrenal metastasis from non‐small cell lung cancer is very poor. A recent report described the efficacy of the surgical removal of adrenal metastasis when solitary. However, metachronous bilateral adrenal metastasis is extremely rare, and a treatment strategy has not been established. CASE PRESENTATION: Herein, we describe a 52‐year‐old Asian male who presented with a right adrenal metastasis of non‐small cell lung cancer 8 months after immunochemotherapy and surgical resection of the lung. He underwent combined systemic treatment and a laparoscopic right adrenalectomy; however, after 9 months, a metachronous left adrenal metastasis emerged. A subsequent laparoscopic left adrenalectomy and systemic treatment led to long‐term progression‐free survival. CONCLUSION: The appropriate surgical indication and combined systemic treatment of a metachronous bilateral adrenal metastasis in non‐small cell lung cancer may extend the prognosis. John Wiley and Sons Inc. 2022-08-02 /pmc/articles/PMC9626332/ /pubmed/36341191 http://dx.doi.org/10.1002/iju5.12519 Text en © 2022 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of Japanese Urological Association. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Reports
Tomiyama, Nami
Naiki, Taku
Naiki‐Ito, Aya
Kawai, Tatsuya
Etani, Toshiki
Gonda, Masakazu
Aoki, Maria
Morikawa, Toshiharu
Sugiyama, Yosuke
Yasui, Takahiro
A rare case of long‐term survival from metachronous bilateral adrenal metastasis of lung adenocarcinoma after combined surgical removal and immunochemotherapy
title A rare case of long‐term survival from metachronous bilateral adrenal metastasis of lung adenocarcinoma after combined surgical removal and immunochemotherapy
title_full A rare case of long‐term survival from metachronous bilateral adrenal metastasis of lung adenocarcinoma after combined surgical removal and immunochemotherapy
title_fullStr A rare case of long‐term survival from metachronous bilateral adrenal metastasis of lung adenocarcinoma after combined surgical removal and immunochemotherapy
title_full_unstemmed A rare case of long‐term survival from metachronous bilateral adrenal metastasis of lung adenocarcinoma after combined surgical removal and immunochemotherapy
title_short A rare case of long‐term survival from metachronous bilateral adrenal metastasis of lung adenocarcinoma after combined surgical removal and immunochemotherapy
title_sort rare case of long‐term survival from metachronous bilateral adrenal metastasis of lung adenocarcinoma after combined surgical removal and immunochemotherapy
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626332/
https://www.ncbi.nlm.nih.gov/pubmed/36341191
http://dx.doi.org/10.1002/iju5.12519
work_keys_str_mv AT tomiyamanami ararecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy
AT naikitaku ararecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy
AT naikiitoaya ararecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy
AT kawaitatsuya ararecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy
AT etanitoshiki ararecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy
AT gondamasakazu ararecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy
AT aokimaria ararecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy
AT morikawatoshiharu ararecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy
AT sugiyamayosuke ararecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy
AT yasuitakahiro ararecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy
AT tomiyamanami rarecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy
AT naikitaku rarecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy
AT naikiitoaya rarecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy
AT kawaitatsuya rarecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy
AT etanitoshiki rarecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy
AT gondamasakazu rarecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy
AT aokimaria rarecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy
AT morikawatoshiharu rarecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy
AT sugiyamayosuke rarecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy
AT yasuitakahiro rarecaseoflongtermsurvivalfrommetachronousbilateraladrenalmetastasisoflungadenocarcinomaaftercombinedsurgicalremovalandimmunochemotherapy